RE:RE:This cant be good for the sectorThere is so much garbage flea market CBD product in the US currently..
This is going to shake out all the garbage players out there. What will remain are the legit companies doing scientific research. I see it as a filtering process. The beauty of it, Canada is much open and is completely qualitifed to conduct reseach and human trials for product and having that capability in Canada as a company could give you a big edge to approach the FDA with data and a Health Canada approved drug for treatment of inflammation, pain, etc. Companies without that type of capability wont make it through the front door of the FDA.
Hexo is way ahead. IMO